Lanean...
Mineralocorticoid Receptor Antagonists for Treatment of Hypertension and Heart Failure
Spironolactone and eplerenone are both mineralocorticoid-receptor antagonists. These compounds block both the epithelial and nonepithelial actions of aldosterone, with the latter assuming increasing clinical relevance. Spironolactone and eplerenone both affect reductions in blood pressure either as...
Gorde:
| Argitaratua izan da: | Methodist Debakey Cardiovasc J |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
The Methodist Hospital Houston, Texas
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4814010/ https://ncbi.nlm.nih.gov/pubmed/27057293 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14797/mdcj-11-4-235 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|